Sleep disorder diagnosis a future pharmacy service

Screening for sleep disorders in community pharmacies can improve the rate of diagnosis, new Australian research has revealed.

A cluster-randomised trial of 325 patients, drawn from 23 community pharmacies, found that 67% were at risk of obstructive sleep apnoea (OSA), insomnia or restless legs syndrome after they were screened for these conditions.

Two different screening methods were used – a subjective risk-assessment-only questionnaire for common sleep disorder screening, and the same risk-assessment questionnaire plus measurement with a nasal flow monitor – and both were found to be